CN Stock MarketDetailed Quotes

Shanghai C&D INNOSTIC Medical Technology Group (301584)

Watchlist
  • 21.28
  • +0.49+2.36%
Trading Jun 12 10:57 CST
8.97BMarket Cap31.39P/E (TTM)

Shanghai C&D INNOSTIC Medical Technology Group (301584) Key Financial Indicators

301584 Earnings per Share (EPS)

According to the latest financial report of Shanghai C&D INNOSTIC Medical Technology Group, the latest earnings per share (TTM) for the company is 0.15. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

301584 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out Shanghai C&D INNOSTIC Medical Technology Group's latest financial report to see how much their book value per share (BVPS) is currently at 5.15.

Currency: CNY

Cumulative Quarterly

Loading...

301584 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Shanghai C&D INNOSTIC Medical Technology Group shows that the company's current ratio is 1.17, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

301584 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Shanghai C&D INNOSTIC Medical Technology Group, the quick ratio is 0.90, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

301584 Return on Equity (ROE)

Want to learn more about the financial health of Shanghai C&D INNOSTIC Medical Technology Group? The latest ROE figure is 3.04%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

301584 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Shanghai C&D INNOSTIC Medical Technology Group, the total asset return on investment (ROA) is 0.56%.

Currency: CNY

Cumulative Quarterly

Loading...

301584 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Shanghai C&D INNOSTIC Medical Technology Group's latest financial report to see how their gross margin is doing - currently at 8.04%.

Currency: CNY

Cumulative Quarterly

Loading...

301584 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Shanghai C&D INNOSTIC Medical Technology Group, the net profit margin is 1.87%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th, Eastern Time, Trump stated he would launch a military strike against Iran that evening, targeting core oil facil Show More